Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:58 PM
Ignite Modification Date:
2025-12-24 @ 12:58 PM
NCT ID:
NCT06719661
Eligibility Criteria:
Inclusion Criteria:
* Patients with a diagnosis of type 2 diabetes mellitus having either dual or triple therapy, including (metformin, sulfonylurea, and/or DPP-4 inhibitors).
* HbA1c level between 7.0% and 10% and patients with HbA1c above 10% but refusing insulin therapy.
* Willing to provide informed consent.
Exclusion Criteria:
* Presence of comorbidities (e.g., severe renal impairment (eGFR \< 30 mL/min/1.73m²), thyroid dysfunction, liver dysfunction).
* Presence of type 1 diabetes mellitus.
* History of diabetic ketoacidosis.
* Pregnancy or breastfeeding.
* Cognitive impairment or inability to provide informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
70 Years
Study:
NCT06719661
Study Brief:
Protocol Section:
NCT06719661